These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


820 related items for PubMed ID: 9530478

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Indications for the use of human albumin in anesthesia and intensive care medicine].
    Adams HA, Michels R, Hempelmann G.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1993 Apr; 28(2):66-74. PubMed ID: 8324107
    [Abstract] [Full Text] [Related]

  • 3. Plasma substitutes.
    Boldt J, Suttner S.
    Minerva Anestesiol; 2005 Dec; 71(12):741-58. PubMed ID: 16288182
    [Abstract] [Full Text] [Related]

  • 4. Volume replacement in critically ill patients with acute renal failure.
    Ragaller MJ, Theilen H, Koch T.
    J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S33-9. PubMed ID: 11251029
    [Abstract] [Full Text] [Related]

  • 5. Volume replacement in trauma.
    Ribeiro MA, Epstein MG, Alves LD.
    Ulus Travma Acil Cerrahi Derg; 2009 Jul; 15(4):311-6. PubMed ID: 19669957
    [Abstract] [Full Text] [Related]

  • 6. Colloids versus crystalloids as volume substitutes: clinical relevance of the serum oncotic pressure.
    Lundsgaard-Hansen P, Pappova E.
    Ann Clin Res; 1981 Jul; 13 Suppl 33():5-17. PubMed ID: 7342844
    [Abstract] [Full Text] [Related]

  • 7. Effects of a hydroxyethylstarch solution on plasma colloid osmotic pressure in acutely ill patients.
    Mbaba Mena J, De Backer D, Vincent JL.
    Acta Anaesthesiol Belg; 2000 Jul; 51(1):39-42. PubMed ID: 10806521
    [Abstract] [Full Text] [Related]

  • 8. The efficacy and safety of colloid resuscitation in the critically ill.
    Hartog CS, Bauer M, Reinhart K.
    Anesth Analg; 2011 Jan; 112(1):156-64. PubMed ID: 21127276
    [Abstract] [Full Text] [Related]

  • 9. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 10. [A new hydroxyethyl starch for volume replacement: Elohes 6%].
    Medel J, Baron JF.
    Rev Esp Anestesiol Reanim; 1998 Nov; 45(9):389-96. PubMed ID: 9847657
    [Abstract] [Full Text] [Related]

  • 11. Recent developments in European colloid solutions.
    Dieterich HJ.
    J Trauma; 2003 May; 54(5 Suppl):S26-30. PubMed ID: 12768098
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of 5% human albumin and 6% 200/0.5 HES as exclusive colloid components in large surgical interventions].
    Vogt N, Bothner U, Georgieff M.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1994 May; 29(3):150-6. PubMed ID: 7519062
    [Abstract] [Full Text] [Related]

  • 13. Attenuation of capillary leakage by hydroxyethyl starch (130/0.42) in a porcine model of septic shock.
    Marx G, Pedder S, Smith L, Swaraj S, Grime S, Stockdale H, Leuwer M.
    Crit Care Med; 2006 Dec; 34(12):3005-10. PubMed ID: 16971858
    [Abstract] [Full Text] [Related]

  • 14. Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia.
    van der Heijden M, Verheij J, van Nieuw Amerongen GP, Groeneveld AB.
    Crit Care Med; 2009 Apr; 37(4):1275-81. PubMed ID: 19242338
    [Abstract] [Full Text] [Related]

  • 15. [Volume replacement with hydroxyethyl starch: is there an influence on kidney function?].
    Suttner S, Boldt J.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):71-7. PubMed ID: 14767795
    [Abstract] [Full Text] [Related]

  • 16. High molecular weight hydroxyethyl starch solutions are not more effective than a low wmolecular weight hydroxyethyl starch solution in a porcine model of septic shock.
    Simon TP, Schuerholz T, Haugvik SP, Forberger C, Burmeister MA, Marx G.
    Minerva Anestesiol; 2013 Jan; 79(1):44-52. PubMed ID: 23090105
    [Abstract] [Full Text] [Related]

  • 17. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin.
    Vogt NH, Bothner U, Lerch G, Lindner KH, Georgieff M.
    Anesth Analg; 1996 Aug; 83(2):262-8. PubMed ID: 8694303
    [Abstract] [Full Text] [Related]

  • 18. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis.
    Niemi TT, Kuitunen AH.
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):373-8. PubMed ID: 15752404
    [Abstract] [Full Text] [Related]

  • 19. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
    Kröll W, Pölz W, Colombo T, Steindorfer P.
    Wien Klin Wochenschr; 1994 Mar; 106(13):416-21. PubMed ID: 7522379
    [Abstract] [Full Text] [Related]

  • 20. [Haemodynamic effects following preoperative hypervolemic haemodilution with hypertonic hyperoncotic colloid solutions in coronary artery bypass graft surgery].
    Molter GP, Soltész S, Larsen R, Baumann-Noss S, Biedler A, Silomon M.
    Anaesthesist; 2003 Oct; 52(10):905-18. PubMed ID: 14618246
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 41.